EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ATPC

ATPC

Agape ATP Corp

Next earnings Aug 11, 2026

Hold
$3.13
▲ +4.33%
$3.13▼ -95.43%
over 1Y
L $1.83EODHDH $74.40
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.3%
1W-13.8%
1M+9.8%
3M-2.2%
YTD-40.4%
1Y-95.4%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)

Revenue grew 15.2% YoY; but unprofitable (net margin -149.6%).

Revenue (FY2025) $1.52M · FY2025

Agape ATP Corp shows $1.52M in FY2025 revenue (+15.2% YoY), a -149.6% net margin, and -10.2% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.02M$1.86M$1.43M$1.32M$1.52M
Gross profit$720K$1.19M$937K$759K$838K
Operating income-$1.86M-$1.53M-$2.15M-$2.57M-$3.26M
Net income-$2.52M-$1.69M-$2.10M-$2.47M-$2.28M
Diluted EPS—-$0.02-$0.55-$31.74-$2.85
Net margin-248.2%-90.9%-146.9%-186.8%-149.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.99M
EV / EBITDA—
EV / Sales2.0
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-72.8%
FCF yield-77.2%

Quality & risk

ROIC (est.)-11.5%
Free cash flow-$2.42M
Total debt—
Net cash$140K
Altman Z-Score0.91 distress
Piotroski F-Score3/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-98.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — late filing notice (2026-03-31). Worth a closer look.
  1. S-1 Securities registration2026-06-08
  2. 10-Q Quarterly report2026-05-15
  3. 10-K Annual report2026-04-13
  4. NT 10-K Late filing notice2026-03-31
  5. 8-K Delisting notice2026-03-12
  6. 8-K Material agreement2026-03-10
  7. 8-K Material event2026-02-06
  8. S-3 Shelf registration (potential raise)2026-02-06
  9. 8-K Delisting notice2026-02-05

Recent filings

all on EDGAR ↗
S-1Filing2026-06-08open ↗10-QPeriod ending 2026-03-312026-05-15open ↗10-KPeriod ending 2025-12-312026-04-13open ↗NT 10-KPeriod ending 2025-12-312026-03-31open ↗8-KPeriod ending 2026-03-122026-03-12open ↗8-KPeriod ending 2026-03-102026-03-10open ↗S-3Filing2026-02-06open ↗8-KPeriod ending 2026-02-062026-02-06open ↗8-KPeriod ending 2026-02-052026-02-05open ↗8-KPeriod ending 2026-01-302026-02-02open ↗8-KPeriod ending 2026-01-272026-01-29open ↗DEFR14AFiling2026-01-28open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueB
GrowthB+
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$1.52M
+15.2% YoY
Net margin
-149.6%
ROE
-10.2%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.52M+15.2%
Net income-$2.28M+7.7%
Gross profit$838K+10.4%
Operating income-$3.26M-26.6%
Diluted EPS-$2.85+91.0%
Cash & equivalents$140K-93.1%
Total assets$24.6M+659.0%
Total liabilities$2.17M+65.2%
Stockholders' equity$22.5M+1062.0%
Gross: 55.0%Op.: -213.7%L/E: 0.10x

Frequently asked

Is Agape ATP Corp (ATPC) a buy?
ATPC currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 15.2% YoY; but unprofitable (net margin -149.6%).
What is Agape ATP Corp's quality score?
ATPC scores 56.17647058823529/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001713210, latest 10-Q filed 2026-05-15) · EODHD · as of 6/20/2026, 7:45:53 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Recent news

market news →
Most and least shorted small-to-mid-cap stocksBullish
seekingalpha.com· 2026-04-06
BC-Most Active StocksBullish
finance.yahoo.com· 2026-01-15
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum BuyingBullish
nasdaq.com· 2025-12-11
Why Agape ATP Corporation (ATPC) is Surging in 2025Bullish
finance.yahoo.com· 2025-04-30
Which stocks are moving on Monday?Bullish
chartmill.com· 2025-04-07
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.55%Bullish
finance.yahoo.com· 2024-08-30

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score56 vs 67
Revenue growth15.2% vs 7.1%
Net margin-149.6% vs 10.5%
Return on equity-10.2% vs 12.3%
P/E— vs 25.5